What it is
Peptides acting on it
Evidence
[literature]GIP is one of retatrutide’s three receptor arms in the triple agonist that hit up to 28.3% weight loss in Phase 3 TRIUMPH-1 (2026). — SOURCE-retatrutide-triumph1-phase3
[literature] GIP is one of retatrutide’s three receptor arms in the triple agonist that hit up to 28.3% weight loss in Phase 3 TRIUMPH-1 (2026). — SOURCE-retatrutide-triumph1-phase3